Abstract
Although the detection of metastases radically changes prognosis of and treatment decisions for a cancer patient, clinically undetectable micrometastases hamper a consistent classification into localized or metastatic disease. This chapter discusses mathematical modeling efforts that could help to estimate the metastatic risk in such a situation. We focus on two approaches: (1) a stochastic framework describing metastatic emission events at random times, formalized via Poisson processes, and (2) a deterministic framework describing the micrometastatic state through a size-structured density function in a partial differential equation model. Three aspects are addressed in this chapter. First, a motivation for the Poisson process framework is presented and modeling hypotheses and mechanisms are introduced. Second, we extend the Poisson model to account for secondary metastatic emission. Third, we highlight an inherent crosslink between the stochastic and deterministic frameworks and discuss its implications. For increased accessibility the chapter is split into an informal presentation of the results using a minimum of mathematical formalism and a rigorous mathematical treatment for more theoretically interested readers.
Both authors equally contributed to this work.
References
Çınlar E (2011) Probability and stochastics. Graduate texts in mathematics, vol 261. Springer, New York
Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584
Nguyen DX, Bos PD, Massagué J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274–284
Sahai E (2007) Illuminating the metastatic process. Nat Rev Cancer 7(10):737–749
WHO (2015) Cancer fact sheet. http://www.who.int/mediacentre/factsheets/fs297/en/ . Accessed 14 Jan 2016
Pantel K, Cote RJ, Fodstad O (1999) Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91(13):1113–1124
Scott JG, Gerlee P, Basanta D, Fletcher AG, Maini PK, Anderson ARA (2013) Mathematical modeling of the metastatic process. In: Malek A (ed) Experimental metastasis: modeling and analysis. Springer, Dordrecht, pp 189–208
Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127(4):679–695
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Michor F, Nowak MA, Iwasa Y (2006) Stochastic dynamics of metastasis formation. J Theor Biol 240(4):521–530
Haeno H, Michor F (2010) The evolution of tumor metastases during clonal expansion. J Theor Biol 263(1):30–44
Anderson AR, Quaranta V (2008) Integrative mathematical oncology. Nat Rev Cancer 8(3):227–234
Koscielny S, Tubiana M, Lê MG, Valleron J, Mouriesse H, Contesso G, Sarrazin D (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49(6):709–715
Michaelson JS, Silverstein M, Wyatt J, Weber G, Moore R, Halpern E, Kopans DB, Hughes K (2002) Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95(4):713–723
van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009
Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, response and postvascular dormancy. Cancer Res 59:4770–5
Norton L (1988) A Gompertzian model of human breast cancer growth. Cancer Res 48:7067–7071
Verga F (2010) Modélisation mathématique de processus métastatiques. Ph.D. thesis, Aix-Marseille Université
Hart D, Shochat E, Agur Z (1998) The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer 78:382–387
Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JML, Hlatky L, Hahnfeldt P (2014) Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol 10(8):e1003800
Bartoszyński R, Edler L, Hanin L, Kopp-Schneider A, Pavlova L, Tsodikov A, Zorin A, Yakovlev A (2001) Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis. Math Biosci 171:113–142
Hanin L, Rose J, Zaider M (2006) A stochastic model for the sizes of detectable metastases. J Theor Biol 243:407–417
Iwata K, Kawasaki K, Shigesada N (2000) A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol 203:177–186
Hartung N, Mollard S, Barbolosi D, Benabdallah A, Chapuisat G, Henry G, Giacometti S, Iliadis A, Ciccolini J, Faivre C, Hubert F (2014) Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice. Cancer Res 74:6397–6407
Benzekry S, Tracz A, Mastri M, Corbelli R, Barbolosi D, Ebos JML (2016) Modeling spontaneous metastasis following surgery: an in vivo-in silico approach. Cancer Res 76(3):535–547
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559–1564
Newton PK, Mason J, Bethel K, Bazhenova LA, Nieva J, Kuhn P (2012) A stochastic Markov chain model to describe lung cancer growth and metastasis. PLoS One 7(4):e34637
Newton PK, Mason J, Bethel K, Bazhenova L, Nieva J, Norton L, Kuhn P (2013) Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res 73(9):2760–2769
Comen E, Norton L, Massague J (2011) Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 8(6):369–377
Scott JG, Basanta D, Anderson AR, Gerlee P (2013) A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth. J R Soc Interface 10(82):20130011
Hanin L, Zaider M (2011) Effects of surgery and chemotherapy on metastatic progression of prostate cancer: evidence from the natural history of the disease reconstructed through mathematical modeling. Cancers 3(3):3632–3660
Wheldon TE (1988) Mathematical models in cancer research. Medical science series. Adam Hilger, Bristol/Philadelphia
Benzekry S, Gandolfi A, Hahnfeldt P (2014) Global dormancy of metastases due to systemic inhibition of angiogenesis. PLoS One 9(1):e84249
Bethge A, Schumacher U, Wedemann G (2015) Simulation of metastatic progression using a computer model including chemotherapy and radiation therapy. J Biomed Inform 57:74–87
Lewis PAW, Shedler GS (1979) Simulation of nonhomogeneous poisson processes by thinning. Nav Res Log Q 26(3):403
Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Mukoyama S, Yasuda S, Tajima T, Makuuchi H, Murayama C (2003) Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 50(53):1362–1366
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241
Batchelor GK (1967) An introduction to fluid dynamics. Cambridge University Press, Cambridge
Barbolosi D, Benabdallah B, Hubert F, Verga F (2009) Mathematical and numerical analysis for a model of growing metastatic tumors. Math Biosci 218:1–14
Hartung N (2015) Efficient resolution of metastatic tumour growth models by reformulation into integral equations. Discrete Contin Dyn Syst B 20:445–467
Lavielle M (2014) Mixed effects models for the population approach. models, tasks, methods and tools. Chapman & Hall/CRC biostatistics series. Chapman & Hall/CRC, Boca Raton
Tornøe CW, Overgaard RV, Agersø H, Nielsen HA, Madsen H, Jonsson EN (2005) Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations. Pharm Res 22(8):1247–1258
Bulfoni M, Gerratana L, Del Ben F, Marzinotto S, Sorrentino M, Turetta M, Scoles G, Toffoletto B, Isola M, Beltrami CA, Di Loreto C, Beltrami AP, Puglisi F, Cesselli D (2016) In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis. Breast Cancer Res 18(1):30
Paoletti C, Hayes DF (2016) Circulating tumor cells. Adv Exp Med Biol 882:235–258
Chen LL, Blumm N, Christakis NA, Barabasi AL, Deisboeck TA (2009) Cancer metastasis networks and the prediction of progression patterns. Br J Cancer 101(5):749–758
Acknowledgements
The authors thank Florence Hubert, Charlotte Kloft, and Andrea Henrich for suggestions and critical reading of the manuscript. NH gratefully acknowledges financial support by the Agence Nationale de la Recherche under grant ANR-09-BLAN-0217-01.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
A Appendix: Proofs of Results of Section 5.4
A Appendix: Proofs of Results of Section 5.4
The proofs provided in this section are based on the following classical result on Poisson random measures. We refer to [45, Chap. 6, pp. 251] for further details. Also, note that this result directly yields Eqs. 2 through 5.
Proposition A.1.
Let (N t ) t ≥ 0 be a PP with intensity λ and P the corresponding Poisson random measure. We have for \( \phi, \psi \in {L}^1\left({\mathbb{R}}^{+},\lambda (u) du\right)\cap {L}^2\left({\mathbb{R}}^{+},\lambda (u) du\right) \)
and
In other words, we can write the first order moment of the Poisson random measure P in a more compact form
as well as its second order moment
Moreover, to simplify notations in the forthcoming computations, we introduce the following convolution-like notation: for functions ϕ, ψ
1.1 A.1 Proof of Proposition 5.1
We first need to establish the following lemma, which is proven further below.
Lemma A.1.
We have
where e m, f has been introduced in Proposition 5.2.
This is not exactly the renewal equation we want. To derive the desired equation (Eq. 10) we just have to make the following remark. Taking λ p = λ m , Lemma A.1 gives that e m, f satisfies
Hence, from (Eq. 17), we have
Now, let T > 0, we have from the last line of (Eq. 18) that for all t ∈ [0, T],
which gives using Gronwall’s inequality
As a result, e f (t) < +∞ for all t ≥ 0 since T is arbitrary, and also
Finally, using that t ↦ SMO f (t) is an increasing non-negative function, we have
and then
Proof (of Lemma A.1).
Let us start with the following remark. According to the recursive definition (Eq. 11) of our PP cascade, one has
where all the times
are independent of \( {\Pi}^{(1)}:= {\left({T}^{\left({n}_1\right)}\right)}_{n_1\ge 1} \).
Now, from this consideration, by taking apart the first generation of metastasis, we can rewrite SMO f as follows:
with
which are independent of \( {\Pi}^{(1)} \). Note that all the times
can be defined following (Eq. 11), but with λ m as intensity for all the PPs since we consider all the times from the second generation. Therefore, \( {\left({\mathrm{SMO}}_{n_1,f}\right)}_{n_1\ge 1} \) are all independent. Moreover, the shape of all the \( {\mathrm{SMO}}_{n_1,f} \) is similar to SMO f except that the PPs in the cascade have all λ m for intensity. Hence, all the \( {\mathrm{SMO}}_{n_1,f} \) have the same law as SMO m, f .
Using Proposition A.1 with the Poisson random measure P (1)(du) associated to (N t (1)) t ≥ 0 (with intensity λ p ), it is direct to see that
For the second term, using standard properties of the conditional expectation (especially \( \mathbb{E}\left[X\right]=\mathbb{E}\left[\mathbb{E}\left[X|Y\right]\right] \)), one has
with
and then
This, together with Proposition A.1, yields
which concludes the proof of (Eq. 17). □
1.2 A.2 Proof of Proposition 5.2
Using the same strategy as for (Eq. 18), the proof of (Eq. 15) consists only in proving the following relation:
with v m, f (t): = var[SMO m, f (t)]. Knowing Proposition 5.1 and the formula of the variance, one can focus on the term \( {e}_f^{(2)}(t):= \mathbb{E}\left[{\mathrm{SMO}}_f^2(t)\right] \). Using (Eq. 21), we have to compute three terms
The Term \( \mathbb{E}\left[{I}^2\right] \)
Reminding that \( I={\int}_0^tf\left({X}_s\left(\right.t-u\right)\left)\right.{P}^{(1)}(du) \), and using Proposition A.1, it is direct that
The Term \( \mathbb{E}\left[ IJ\right] \)
Using standard properties of the conditional expectation, and that for all n 1 ≥ 1
we have using (Eq. 22)
As result, according to Proposition A.1, we have
The Term \( \mathbb{E}\left[{J}^2\right] \)
To compute this term we have to consider two cases
Following (Eq. 22), but with SMO n, f 2 instead, we have
where \( {e}_{m,f}^{(2)}(t):= \mathbb{E}\left[{\mathrm{SMO}}_{m,f}^2(t)\right] \). Now using that \( {\mathrm{SMO}}_{n_1^1,f} \) and \( {\mathrm{SMO}}_{n_1^2,f} \) are independent for n 1 1 ≠ n 1 2, we have, using (Eq. 22) and Proposition A.1 one more time,
Combining the three previous computations, we obtain
Considering this equation for λ p = λ m , we obtain as for the expectation a renewal equation for e m, f (2), which yields for all t > 0
and then for all T > 0,
using Gronwall’s inequality and Proposition 5.1. This proves that \( \mathbb{E}\left[{\mathrm{SMO}}_{m,f}^2(t)\right]<+\infty \) for all t ≥ 0, and then \( \mathbb{E}\left[{\mathrm{SMO}}_f^2(t)\right]<+\infty \) by going back to (Eq. 24). Now, rewriting (Eq. 24), we obtain
which is (Eq. 23).
1.3 A.3 Proof of Theorem 5.2
Using that X m (s) ∈ [x m 0, x m ∞] for all \( s\in {\mathbb{R}}^{+} \), the σ-finiteness and absolute continuity of μ t (for any t ≥ 0) are direct consequences of (Eq. 19). Denoting by \( {\overset{\sim }{\rho}}_t \) its Radon–Nikodým density, Proposition 5.1 and Theorem 5.1 then yield
for all \( f\in C\left(\left[{x}_m^0,{x}_m^{\infty}\right]\right)\cap {L}^{\infty}\left(\left[{x}_m^0,{x}_m^{\infty}\right]\right) \), which concludes the proof.
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Gomez, C., Hartung, N. (2018). Stochastic and Deterministic Models for the Metastatic Emission Process: Formalisms and Crosslinks. In: von Stechow, L. (eds) Cancer Systems Biology. Methods in Molecular Biology, vol 1711. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7493-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7493-1_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7492-4
Online ISBN: 978-1-4939-7493-1
eBook Packages: Springer Protocols